ArticleInfectious agents and cancer2026
Genotypes of human papillomavirus and clinical pathological features among patients with anal carcinoma in North-western Tanzania.
Article in Infectious agents and cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAnal carcinoma is an increasingly significant public health issue, mainly caused by infection with high-risk human papillomavirus (HPV). Despite this, there is limited data on the distribution of HPV genotypes and their associated clinicopathological characteristics among patients in Tanzania. This study aimed to describe the range of HPV genotypes and to explore their relationship with clinical and pathological features in patients diagnosed with anal carcinoma in Northwestern Tanzania.
methodsThis longitudinal, analytical, laboratory-based study was conducted at Bugando Medical Centre between 30th April 2023 and 02nd January 2025. A total of 60 formalin-fixed paraffin-embedded (FFPE) tissue blocks from histologically confirmed cases of anal carcinoma were included. DNA was extracted, and high-risk HPV genotyping was performed using the Anyplex™ II HPV28 PCR assay. Data were analysed using Stata version 15, and statistical significance was defined as a p-value < 0.05.
resultsHigh-risk HPV DNA was detected in 35 of the 60 cases (58.3%). Among HPV-positive patients, 26 (74.3%) were female, and 09 (25.7%) were male. HPV16 was the most frequently identified genotype (50.0%), followed by HPV18 (19.6%) and HPV33 (8.7%). Multiple HPV genotypes were detected in 31.4% of positive samples. HPV-negative anal carcinoma was significantly associated with tumour involvement of both the anal canal and surgical margins, advanced T stages (stages III and IV), lymph node involvement, distant metastasis, and tumour size greater than 2 cm (all p < 0.001). Keratinising squamous cell carcinoma was the predominant histological subtype (51.7%), and half of the study participants (50.0%) were HIV-positive.
conclusionHigh-risk HPV infection, particularly with HPV16 and HPV18, is common among patients with anal carcinoma in Northwestern Tanzania and anal carcinoma with HPV negative status is associated with critical clinicopathological characteristics. Strengthening HPV vaccination, screening, and awareness initiatives could substantially reduce the burden of anal carcinoma in Tanzania.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.